Fox Run Management L.L.C. Takes $669,000 Position in Genpact Limited (NYSE:G)

Fox Run Management L.L.C. bought a new position in shares of Genpact Limited (NYSE:GFree Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 15,573 shares of the business services provider’s stock, valued at approximately $669,000.

A number of other hedge funds also recently modified their holdings of the stock. SRH Advisors LLC acquired a new stake in Genpact during the fourth quarter worth about $26,000. Manchester Capital Management LLC acquired a new stake in shares of Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC increased its stake in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock valued at $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. raised its position in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp raised its position in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock valued at $69,000 after purchasing an additional 453 shares in the last quarter. Institutional investors own 96.03% of the company’s stock.

Insider Transactions at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Analyst Ratings Changes

G has been the topic of several recent analyst reports. Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Needham & Company LLC lifted their target price on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, February 7th. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price target for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $48.44.

Check Out Our Latest Research Report on G

Genpact Price Performance

Genpact stock opened at $49.93 on Tuesday. The stock’s 50 day moving average is $50.38 and its 200 day moving average is $44.78. Genpact Limited has a one year low of $30.23 and a one year high of $56.76. The firm has a market cap of $8.77 billion, a P/E ratio of 17.58, a P/E/G ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.

Genpact (NYSE:GGet Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, research analysts expect that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.36%. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. Genpact’s dividend payout ratio is presently 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.